Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $136.00 | Total: $680.00 |
| 1 | 10 | $115.20 | Total: $1,152.00 |
| 1 | 25 | $97.60 | Total: $2,440.00 |
| 1 | 50 | $83.20 | Total: $4,160.00 |
| 1 | 100 | $72.00 | Total: $7,200.00 |
Overview
Senexin C is a novel orally active and specific CDK819 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.
Chemical Properties
| Molecular Formula | C28H27N5O |
| Molecular Weight | 449.55 |
| CAS Numbers | 2375554-02-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | N#CC=1C=CC2=NC=CC(NCCC=3C=CC4=CC(=CC=C4C3)C(=O)N5CCN(C)CC5)=C2C1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Zhang L, et al. A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK819 Mediator Kinase with Tumor-Enriched Pharmacokinetics. J Med Chem. 2022; 65[4] 3420-3433.